Search

[Display omitted] • For the first time, Raman spectroscopy combined with deep learning is used for the classification and identification of red wine origin. • Corresponding biomarkers identified by Raman spectroscopy of red wine. • Classification of red wine origin by PCA analysis. • Comparative experiment of four deep learning models. • The combination of MCNN and Raman spectroscopy achieves the best results for the classification of red wine origin. In this study, we combined Raman spectroscopy with deep learning for the first time to establish an accurate, simple, and fast method to identify the origin of red wines. We collected Raman spectra from 200 red wine samples of the Cabernet Sauvignon variety from four different origins with a portable Raman spectrometer. The red wine samples, made in 2021, were from the same producer in China. Differences were found by analyzing the Raman spectra of red wine samples. These differences are mainly caused by ethanol, carboxylic acids, and polyphenols. After further analysis, for different origins, the different performances of these substances on the Raman spectrum are related to the climate and geographical conditions of the origin. The Raman spectra were analyzed by principal component analysis (PCA). The data with PCA dimensionality reduction were imported into an artificial neural network (ANN), multifeature fusion convolutional neural network (MCNN), GoogLeNet, and residual neural network (ResNet) to establish red wine origin identification models. The classification results of the model prove that climate, geography, and other conditions can provide support for the classification of red wine origin. The experiments showed that all four models performed well, among which MCNN performed the best with 93.2% classification accuracy, and the area under the curve (AUC) was 0.987. This study provides a new means to classify the origin of red wine and opens up new ideas for identifying origins in the food field. [ABSTRACT FROM AUTHOR]

[Display omitted] • Differences in the biochemical composition of seven types of tissues are analyzed. • A new one-dimensional convolutional hierarchical network (H-CNN) is proposed. • H-CNN classifies tissue samples in a hierarchy from coarse to fine. • H-CNN outperforms traditional classification models. Cervical cancer is one of the most common cancers with a long latent period and slow onset process. Early and accurate identification of the stage of cervical cancer can significantly improve the cure rate and patient survival time. In this study, we collected 699 Raman spectral data of tissue sections from 233 different patients. We analyzed and compared the characteristics and differences of the mean Raman spectra of the seven tissues and pointed out the main differences in the biochemical composition of the seven tissues. In this study, 1D hierarchical convolutional neural network (H-CNN) is proposed by integrating the prior knowledge of hierarchical classification relations with the research of deep learning in Raman spectroscopy. H-CNN is based on CNN and is added with three network branches. Hierarchical classification is performed from coarse to fine for tissue samples of cervicitis, Low-grade Squamous Cell Carcinoma, High-grade Squamous Cell Carcinoma, Well Differentiated Squamous Cell Carcinoma, Moderately Differentiated Squamous Cell Carcinoma, Poorly Differentiated Squamous Cell Carcinoma and cervical adenocarcinoma. To evaluate the recognition performance of H-CNN, we compared it with traditional methods such as Bayesian classifier (NB), decision tree classifier (DT), support vector machine classifier (SVM) and CNN. The experimental results show that H-CNN can accurately identify different classes of tissue sections and has apparent advantages in several aspects such as recognition accuracy, stability and sensitivity compared with the other four traditional recognition methods. The classification Macro-Accuracy of H-CNN can reach 94.91%, Macro-Recall can reach 95.31%, Macro-F1 can reach 95.23%, and Macro-AUC can reach 97.35%. The hierarchical classification method proposed in this study can diagnose patients more accurately. This could lay the foundation for further research on Raman spectroscopy as a clinical diagnostic method for cervical cancer. [ABSTRACT FROM AUTHOR]

[Display omitted] • Triple-negative breast cancer and HER2-positive breast cancer are highly malignant, and early diagnosis is helpful to improve the chances of cure. • Serum Raman spectroscopy combined with deep learning algorithms to diagnose triple-negative breast cancer and HER2-positive breast cancer and achieved great diagnostic results. • The proposed method is helpful for early breast cancer diagnosis and can provide a reference for breast cancer patients to make a personalised diagnosis. Breast cancer is common in women, and its number of patients ranks first among female malignant tumors. Breast cancer is highly heterogeneous, and different types of breast cancer have different biological behaviors and prognoses. Therefore, identifying the different types of breast cancer is of great help in formulating individualized treatment plans. Based on serum Raman spectroscopy and deep learning algorithms, we propose a fast and low-cost diagnosis method for screening triple-negative breast cancer, human epidermal growth factor receptor 2 (HER2)-positive breast cancer, and healthy controls. We collected 75 serum samples in this study, including 23 triple-negative breast cancers, 22 HER2-positive breast cancers, and 30 healthy controls. Using the preprocessed Raman spectra as the input of deep learning, three deep learning models, neural network language model (NNLM), bidirectional long-short-term memory network (BiLSTM), and convolutional neural network (CNN), were established, and the accuracy rates of the three models were 87.78%, 90.37%, and 91.11%, respectively. The experimental results demonstrate the feasibility of serum Raman spectroscopy combined with deep learning algorithms to diagnose breast cancer, which can be used as an effective auxiliary diagnosis method for breast cancer. [ABSTRACT FROM AUTHOR]

[Display omitted] • A novel spectral fusion diagnosis technology is proposed. • A new and efficient MFCNN network is designed to process spectral data. • This study explored the potential of spectral fusion technology for the diagnosis of multiple cancers in this complex clinical environment. According to the limited molecular information reflected by single spectroscopy, and the complementarity of FTIR spectroscopy and Raman spectroscopy, we propose a novel diagnostic technology combining multispectral fusion and deep learning. We used serum samples from 45 healthy controls, 44 non-small cell lung cancer (NSCLC), 38 glioma and 37 esophageal cancer patients, and the Raman spectra and FTIR spectra were collected respectively. Then we performed low-level fusion and feature fusion on the spectral, and used SVM, Convolutional Neural Network-Long-Short Term Memory (CNN-LSTM) and the multi-scale convolutional fusion neural network (MFCNN). The accuracy of low-level fusion and feature fusion models are improved by about 10% compared with single spectral models. [ABSTRACT FROM AUTHOR]